Cbl-b silenced human NK cells respond stronger to cytokine stimulation

nork Lametschwandtner, Guenther, Sachet, Monika, Haslinger, Isabella, Mühleisen, Hannes, Loibner, Hans
Argitaratua izan da J Immunother Cancer (2015)

Phase I clinical trial of adoptive cellular immunotherapy with APN401 in patients with solid tumors

nork Triozzi, Pierre, Kooshki, Mitra, Alistar, Angela, Bitting, Rhonda, Neal, Amy, Lametschwandtner, Guenther, Loibner, Hans
Argitaratua izan da J Immunother Cancer (2015)

Treatment of a cancer patient by an adoptive cell therapy protocol combining DC vaccination with cbl-b ex vivo silencing

nork Sachet, Monika, Lametschwandtner, Guenther, Hayden, Hubert, Hassler, Michaela, Loibner, Hans, Triozzi, Pierre, Friedl, Josef
Argitaratua izan da J Immunother Cancer (2015)

Overcoming immune-cell unresponsiveness in cancer

nork Lametschwandtner, Guenther, Ermann, Monika, Sternberger, Ina, Hesterkamp, Thomas, Haslinger, Isabella, Mühleisen, Hannes, Schuster, Manfred, Loibner, Hans
Argitaratua 2013

Long-term continuous infusion of anti-GD2 antibody CH14.18/CHO in relapsed/refractory neuroblastoma patients

nork Lode, Holger, Siebert, Nikolai, Kietz, Silke, Müller, Ina, Schuster, Manfred, Janzek, Evelyne, Wiederkum, Susanne, Mutschlechner, Oliver, Loibner, Hans
Argitaratua 2013

Development of a personalized cellular ex-vivo cbl-b silencing cancer immunotherapy

nork Lametschwandtner, Guenther, Loibner, Hans, Sachet, Monika, Hayden, Hubert, Hassler, Michaela, Schuster, Manfred, Salzberg, Marc, Triozzi, Pierre, Friedl, Josef
Argitaratua izan da J Immunother Cancer (2014)

Recombinant Expression and Characterization of Human and Murine ACE2: Species-Specific Activation of the Alternative Renin-Angiotensin-System

nork Poglitsch, Marko, Domenig, Oliver, Schwager, Cornelia, Stranner, Stefan, Peball, Bernhard, Janzek, Evelyne, Wagner, Bettina, Jungwirth, Helmut, Loibner, Hans, Schuster, Manfred
Argitaratua 2012

Low CD4⁺/CD25⁺/CD127⁻ regulatory T cell- and high INF-γ levels are associated with improved survival of neuroblastoma patients treated with long-term infusion of ch14.18/CHO combin...

nork Troschke-Meurer, Sascha, Siebert, Nikolai, Marx, Madlen, Zumpe, Maxi, Ehlert, Karoline, Mutschlechner, Oliver, Loibner, Hans, Ladenstein, Ruth, Lode, Holger N.
Argitaratua izan da Oncoimmunology (2019)

Neutrophil/Lymphocyte ratio has no predictive or prognostic value in breast cancer patients undergoing preoperative systemic therapy

nork Suppan, Christoph, Bjelic-Radisic, Vesna, La Garde, Marlen, Groselj-Strele, Andrea, Eberhard, Katharina, Samonigg, Hellmut, Loibner, Hans, Dandachi, Nadia, Balic, Marija
Argitaratua izan da BMC Cancer (2015)

Charge heterogeneity: Basic antibody charge variants with increased binding to Fc receptors

nork Hintersteiner, Beate, Lingg, Nico, Zhang, Peiqing, Woen, Susanto, Hoi, Kong Meng, Stranner, Stefan, Wiederkum, Susanne, Mutschlechner, Oliver, Schuster, Manfred, Loibner, Hans, Jungbauer, Alois
Argitaratua izan da MAbs (2016)

Adoptive Transfer of siRNA Cblb-Silenced CD8(+) T Lymphocytes Augments Tumor Vaccine Efficacy in a B16 Melanoma Model

nork Hinterleitner, Reinhard, Gruber, Thomas, Pfeifhofer-Obermair, Christa, Lutz-Nicoladoni, Christina, Tzankov, Alexander, Schuster, Manfred, Penninger, Josef M., Loibner, Hans, Lametschwandtner, Günther, Wolf, Dominik, Baier, Gottfried
Argitaratua 2012

Targeting the Degradation of Angiotensin II with Recombinant ACE2: Prevention of Angiotensin II-dependent Hypertension

nork Wysocki, Jan, Ye, Minghao, Rodriguez, Eva, González-Pacheco, Francisco R., Barrios, Clara, Evora, Karla, Schuster, Manfred, Loibner, Hans, Brosnihan, K. Bridget, Ferrario, Carlos M., Penninger, Josef M., Batlle, Daniel
Argitaratua 2009

Effective combination of innate and adaptive immunotherapeutic approaches in a mouse melanoma model

nork Rakhmilevich, Alexander L., Felder, Mildred, Lever, Lauren, Slowinski, Jacob, Rasmussen, Kayla, Hoefges, Anna, Van De Voort, Tyler J., Loibner, Hans, Korman, Alan J., Gillies, Stephen D., Sondel, Paul M.
Argitaratua izan da J Immunol (2017)

Pharmacokinetics and pharmacodynamics of ch14.18/CHO in relapsed/refractory high-risk neuroblastoma patients treated by long-term infusion in combination with IL-2

nork Siebert, Nikolai, Eger, Christin, Seidel, Diana, Jüttner, Madlen, Zumpe, Maxi, Wegner, Danilo, Kietz, Silke, Ehlert, Karoline, Veal, Gareth J., Siegmund, Werner, Weiss, Michael, Loibner, Hans, Ladenstein, Ruth, Lode, Holger N.
Argitaratua izan da MAbs (2016)

Human Recombinant ACE2 Reduces the Progression of Diabetic Nephropathy

nork Oudit, Gavin Y., Liu, George C., Zhong, JiuChang, Basu, Ratnadeep, Chow, Fung L., Zhou, Joyce, Loibner, Hans, Janzek, Evelyne, Schuster, Manfred, Penninger, Josef M., Herzenberg, Andrew M., Kassiri, Zamaneh, Scholey, James W.
Argitaratua 2010

Impact of HACA on Immunomodulation and Treatment Toxicity Following ch14.18/CHO Long-Term Infusion with Interleukin-2: Results from a SIOPEN Phase 2 Trial

nork Siebert, Nikolai, Troschke-Meurer, Sascha, Marx, Madlen, Zumpe, Maxi, Ehlert, Karoline, Gray, Juliet, Garaventa, Alberto, Manzitti, Carla, Ash, Shifra, Klingebiel, Thomas, Beck, James, Castel, Victoria, Valteau-Couanet, Dominique, Loibner, Hans, Ladenstein, Ruth, Lode, Holger N.
Argitaratua izan da Cancers (Basel) (2018)

Tolerability, response and outcome of high-risk neuroblastoma patients treated with long-term infusion of anti-GD(2) antibody ch14.18/CHO

nork Mueller, Ina, Ehlert, Karoline, Endres, Stefanie, Pill, Lena, Siebert, Nikolai, Kietz, Silke, Brock, Penelope, Garaventa, Alberto, Valteau-Couanet, Dominique, Janzek, Evelyne, Hosten, Norbert, Zinke, Andreas, Barthlen, Winfried, Varol, Emine, Loibner, Hans, Ladenstein, Ruth, Lode, Holger N.
Argitaratua izan da MAbs (2017)

Cytoskeletal defects in Bmpr2-associated pulmonary arterial hypertension

nork Johnson, Jennifer A., Hemnes, Anna R., Perrien, Daniel S., Schuster, Manfred, Robinson, Linda J., Gladson, Santhi, Loibner, Hans, Bai, Susan, Blackwell, Tom R., Tada, Yuji, Harral, Julie W., Talati, Megha, Lane, Kirk B., Fagan, Karen A., West, James
Argitaratua 2012

Pilot trial of the hu14.18-IL2 immunocytokine in patients with completely resectable recurrent stage III or stage IV melanoma

nork Albertini, Mark R., Yang, Richard K., Ranheim, Erik A., Hank, Jacquelyn A., Zuleger, Cindy L., Weber, Sharon, Neuman, Heather, Hartig, Greg, Weigel, Tracey, Mahvi, David, Henry, Mary Beth, Quale, Renae, McFarland, Thomas, Gan, Jacek, Carmichael, Lakeesha, Kim, KyungMann, Loibner, Hans, Gillies, Stephen D., Sondel, Paul M.
Argitaratua izan da Cancer Immunol Immunother (2018)

Tumor-specific inhibition of in situ vaccination by distant untreated tumor sites

nork Morris, Zachary S., Guy, Emily I., Werner, Lauryn R., Carlson, Peter M., Heinze, Clinton M., Kler, Jasdeep S., Busche, Sara M., Jaquish, Abigail A., Sriramaneni, Raghava N., Carmichael, Lakeesha L., Loibner, Hans, Gillies, Stephen D., Korman, Alan J., Erbe, Amy K., Hank, Jacquelyn A., Rakhmilevich, Alexander L., Harari, Paul M., Sondel, Paul M.
Argitaratua izan da Cancer Immunol Res (2018)